Premarket Mover: Palisade Bio Inc (PALI) Down 3.60%

Palisade Bio Inc (PALI) is down Tuesday morning, with the stock decreasing -3.60% in pre-market trading to 1.07. PALI's short-term technical score of 19 indicates that the stock has traded less bullishly over the last month than 81% of stocks on the market. In the Biotechnology industry, which ranks 138 out of 146 industries, Palisade Bio Inc ranks higher than 37% of stocks. Palisade Bio Inc has risen 20.65% over the past month, closing at $0.93 on March 1. During this period of time, the stock fell as low as $0.81 and as high as $1.53. PALI has an average analyst recommendation of Strong Buy. The company has an average price target of $6.00.

PALI has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on PALI!

See Full PALI Report

Palisade Bio Inc has a Long-Term Technical rank of 26. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 74% of the market scoring higher. In the Biotechnology industry which is number 132 by this metric, PALI ranks better than 41% of stocks.

Important Dates for Investors in PALI:

-Palisade Bio Inc is set to release earnings on 6/14/2022. During their last earnings release the company posted EPS of $-3.39. -We do not have a set dividend date for Palisade Bio Inc at this time. Click Here To Get The Full Report on Palisade Bio Inc (PALI)